Med Lett Drugs Ther. 2011 Apr 18;53(1362):29-30.
The FDA has approved Fortesta (Endo), a topical gel, for testosterone replacement therapy in adult males with hypogonadism. It is classified as a Schedule III controlled substance. Table 1 lists some available testosterone products, including 2 other gels.
美国食品药品监督管理局（FDA）已批准外用凝胶Fortesta（Endo公司生产）用于成年性腺功能减退男性的睾酮替代疗法。它被归类为III类管制物质。表1列出了一些现有的睾酮产品，包括另外2种凝胶。
